Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Evaluation of the FLIR One Dynamic Thermal Imaging System in Autologous Breast Reconstruction
Study Type: Health Services
Phase: N/A
NCTID: NCT00000000
Principal Investigator:
Eric Lai
Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer
Study Type: Treatment
Phase: III
NCTID: NCT03488693
Principal Investigator:
Julia White
Comparing Oral Drug Dosing Strategies in Older Patients with Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge CDK Study
Study Type: Treatment
Phase: III
NCTID: NCT06377852
Principal Investigator:
Ryan Rader
A phase IIIb study to characterize the efficacy and safety of Adjuvant ribociclib plus endocrine therapy in a close-to-clinical practice patient population with HR+ HER2? early breast cancer Adjuvant WIDER
Study Type: Treatment
Phase: III
NCTID: NCT05827081
Principal Investigator:
Priyanka Sharma
EXActDNA-003: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated with Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease NSABP B-64
Study Type: Other
Phase: N/A
NCTID: NCT06401421
Principal Investigator:
Julia White
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score
Study Type: Treatment
Phase: III
NCTID: NCT05879926
Principal Investigator:
Lauren Nye
Ice Compress: Randomized Trial of Limb Cryocompression versus continuous Compression versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuropathy
Study Type: Prevention
Phase: N/A
NCTID: NCT05642611
Principal Investigator:
Lauren Nye
OPTIMICE-PCR: De-Escalation Of Therapy In Early-Stage TNBC Patients Who Achieve PCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy
Study Type: Treatment
Phase: III
NCTID: NCT05812807
Principal Investigator:
Priyanka Sharma
A Phase I, First-in-Human Study of MEN2312, a KAT6 inhibitor, as Monotherapy and in Combination in Participants with Advanced Breast Cancer
Study Type: Treatment
Phase: I
NCTID: NCT06638307
Principal Investigator:
Priyanka Sharma
Prospective evaluation of GErmline mutations, Cancer outcome and Tissue biomarkers P.R.O.G.E.C.T.: A registry for patients with triple negative breast cancer and germline mutations
Study Type: Other
Phase: N/A
NCTID: NCT02302742
Principal Investigator:
Priyanka Sharma